Skip to content

Income Tax at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$2.18M-83.1%
Viatris logo
ViatrisVTRS
-$423.7M-670%
AMP
Amphastar PharmaceuticalsAMPH
$3.63M-34.9%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$20.5M+40.9%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$20K-73.0%

Other financials

Income statement

See full
Revenue$22.7M+184%
Operating income-$60.1M-61.8%
Net income-$60.6M-78.6%
EPS (diluted)-$0.61-74.3%

Balance sheet

See full
Cash & equivalents$24.3M-39.0%
Total debt$96.5M+132,122%
Total equity$61.3M-73.2%
Total assets$287.6M-12.1%

Cash flow

See full
Operating cash flow-$44.9M-10.3%
CapEx--100%
Free cash flow-$44.9M-10.1%

Valuation

See full
Market cap$796.41M-48.7%
Enterprise value$868.61M-42.6%
P/S8.1×-7.9×

Profitability

See full
Operating margin-204.5%
Net margin-200%-219pp
FCF margin-177.1%-206pp

Returns & leverage

See full
Return on equity-136.4%-144pp
Debt / equity1.6×+1.6×
Current ratio4.9×-6.1×

Where this comes from

Reported directly by ARS Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: ARS Pharmaceuticals, Inc.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about ARS Pharmaceuticals, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ARS Pharmaceuticals, Inc.'s income tax?
ARS Pharmaceuticals, Inc. (SPRY) reported income tax of -$20K in Q4 2025.
How has ARS Pharmaceuticals, Inc.'s income tax changed year-over-year?
ARS Pharmaceuticals, Inc.'s income tax decreased by 127.8% year-over-year, from $72K to -$20K.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.